Adverse Effects of Multidrug-Resistant Tuberculosis Treatment With a Standardized Regimen: A Report From Iran-Reference-Cited by-同舟云学术

Adverse Effects of Multidrug-Resistant Tuberculosis Treatment With a Standardized Regimen: A Report From Iran

Published:2011-03 Issue:2 Volume:18 Page:e29-e34
ISSN:1075-2765
Container-title:American Journal of Therapeutics
language:en
Short-container-title:

Author:

Baghaei Parvaneh,Tabarsi Payam,Dorriz Donna,Marjani Majid,Shamaei Masoud,Pooramiri Majid Valiollah,Mansouri Davood,Farnia Parisa,Masjedi Mohammadreza,Velayati Aliakbar

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference19 articles.

1. Side effects associated with the treatment of multidrug-resistant tuberculosis.;Torun;Int J Tuberc Lung Dis,2005

2. Current medical treatment for tuberculosis.;Chan;BMJ,2002

3. Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study.;Tabarsi;Scand J Infect Dis,2009

4. Programmes and principles in treatment of multidrug-resistant tuberculosis.;Mukherjee;Lancet,2004

5. Multidrug-resistant tuberculosis.;Seaworth;Infect Dis Clin North Am,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted genome sequencing for tuberculosis drug susceptibility testing in South Africa: a proposed diagnostic pipeline;Access Microbiology;2024-02-01

2. Molecular identification of multiple drug resistance (MDR) strain of Mycobacterium tuberculosis;Molecular Biology Reports;2023-11-16

3. Prevalence of long-term physical sequelae among patients treated with multi-drug and extensively drug-resistant tuberculosis: a systematic review and meta-analysis;eClinicalMedicine;2023-03

4. MDR-TB in Pakistan: Challenges, efforts, and recommendations;Annals of Medicine & Surgery;2022-07

5. Assessment of Adverse Drug Events, Their Risk Factors, and Management Among Patients Treated for Multidrug-Resistant TB: A Prospective Cohort Study From Pakistan;Frontiers in Pharmacology;2022-05-17